Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dutton & Associates Announces Investment Opinion on Neurobiological Technologies: Buy Rating Maintained in Update Report.


Business Editors

NOTE TO EDITORS: The following is an investment opinion issued

by J.M. Dutton & Associates

EL DORADO HILLS, Calif.--(BUSINESS WIRE)--April 16, 2003

J.M. Dutton & Associates continues coverage of Neurobiological neu·ro·bi·ol·o·gy  
n.
The biological study of the nervous system or any part of it.



neuro·bi
 Technologies (Nasdaq:NTII NTII Neurobiological Technologies, Inc. ) with its update report maintaining a Buy rating. The 6-page report by J.M. Dutton senior analyst Sherry Grisewood, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , is available at www.jmdutton.com as well as from Bloomberg, Zacks, First Call, Multex and other leading financial portals.

Clinical data for Neurobiological Technologies' lead product for Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , Memantine, continues to support a high probability of FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval. Results of two separate studies have been recently presented at the American Medical Directors Association annual meeting and at the prestigious American Academy of Neurology The American Academy of Neurology (AAN) is a professional society for neurologists and neuroscientists. As a medical specialty society it was established in 1949 by A.B. Baker of the University of Minnesota to advance the art and science of neurology, and thereby promote the best  Annual Meeting held in Honolulu, Hawaii in early April. NTII's U.S. marketing partner, Forest Laboratories, remains optimistic the FDA will issue an action letter regarding the Memantine submission by the end of 2003. Forest Laboratories' pivotal diabetic neuropathy Diabetic Neuropathy Definition

Diabetic neuropathy is a nerve disorder caused by diabetes mellitus. Diabetic neuropathy may be diffuse, affecting several parts of the body, or focal, affecting a specific nerve and part of the body.
 trial is undergoing data analysis. The last patient was out of follow up in late December and headline study results are expected before the end of April 2003. Paul Freiman, NTII CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , noted on April 8 that the Company is preparing to begin two Phase III trials during the current quarter for the use of Xerecept in the treatment of peritumoral brain swelling.

About Dutton & Associates

Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 19 senior analysts, primarily CFAs, have expertise in many industries including healthcare, technology, finance, banking, mining, gaming and energy. Dutton & Associates provides economically bias-free, continuing analyst coverage of enrolled companies, and its research, estimates, and recommendations are carried in all the major databases serving institutions and online investors.

The cost of enrollment in the Dutton & Associates one-year continuing research program is presently U.S. $25,000 prepaid before commencement of its research activities. Dutton & Associates received $24,000 from the Company for coverage for the year. Dutton & Associates does not accept payment of any of its fees in company stock. Its principals and analysts are prohibited from owning or trading in securities of covered companies. Please review full disclosures, analyst background, and company rating history at www.jmdutton.com before investing.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 16, 2003
Words:374
Previous Article:IIR Industry Alert: Calpine Osprey Energy Center in Florida Surpasses Halfway Construction Mark.
Next Article:IRIDEX Announces First Quarter 2003 Conference Call.



Related Articles
J.M. Dutton & Associates Announces Investment Opinion: Neurobiological Technologies Rating of Strong Buy Maintained By Dutton & Associates.
Dutton & Associates Announces Investment Opinion: Neurobiological Technologies Buy Rating Maintained In Update Report By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Neurobiological Technologies Buy Rating Issued By Dutton & Associates In Initiating Report.
J.M. Dutton & Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated Coverage by...
Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated Coverage by Dutton...
Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating In Initiating Coverage By Dutton...
Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained In Updated Coverage By Dutton...
Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated Coverage by Dutton...
Dutton Associates Announces Investment Opinion: Telkonet Maintained At Strong Speculative Buy Rating; Quarterly Results Give Hint of Progress.
Dutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained In Updated Coverage By Dutton...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles